| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458519 | Pathology - Research and Practice | 2017 | 7 Pages |
Abstract
We suggest that Nectin-4 is a relevant prognostic factor and a therapeutic target in luminalB (HER2 negative) breast cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jasmina Rajc, Damir GugiÄ, Irena Fröhlich, Ksenija MarjanoviÄ, Boris DumenÄiÄ,